271 related articles for article (PubMed ID: 22237406)
1. Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation.
Odusanwo O; Chinthamani S; McCall A; Duffey ME; Baker OJ
Am J Physiol Cell Physiol; 2012 May; 302(9):C1331-45. PubMed ID: 22237406
[TBL] [Abstract][Full Text] [Related]
2. AT-RvD1 combined with DEX is highly effective in treating TNF-α-mediated disruption of the salivary gland epithelium.
Easley JT; Maruyama CL; Wang CS; Baker OJ
Physiol Rep; 2016 Oct; 4(19):. PubMed ID: 27694530
[TBL] [Abstract][Full Text] [Related]
3. ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands.
Nelson JW; Leigh NJ; Mellas RE; McCall AD; Aguirre A; Baker OJ
Am J Physiol Cell Physiol; 2014 Jan; 306(2):C178-85. PubMed ID: 24259417
[TBL] [Abstract][Full Text] [Related]
4. Sex-mediated elevation of the specialized pro-resolving lipid mediator levels in a Sjögren's syndrome mouse model.
Parashar K; Schulte F; Hardt M; Baker OJ
FASEB J; 2020 Jun; 34(6):7733-7744. PubMed ID: 32277856
[TBL] [Abstract][Full Text] [Related]
5. ALX/FPR2 Modulates Anti-Inflammatory Responses in Mouse Submandibular Gland.
Wang CS; Wee Y; Yang CH; Melvin JE; Baker OJ
Sci Rep; 2016 Apr; 6():24244. PubMed ID: 27064029
[TBL] [Abstract][Full Text] [Related]
6. Expression of resolvin D1 biosynthetic pathways in salivary epithelium.
Leigh NJ; Nelson JW; Mellas RE; Aguirre A; Baker OJ
J Dent Res; 2014 Mar; 93(3):300-5. PubMed ID: 24389810
[TBL] [Abstract][Full Text] [Related]
7. Disruption of tight junction structure in salivary glands from Sjögren's syndrome patients is linked to proinflammatory cytokine exposure.
Ewert P; Aguilera S; Alliende C; Kwon YJ; Albornoz A; Molina C; Urzúa U; Quest AF; Olea N; Pérez P; Castro I; Barrera MJ; Romo R; Hermoso M; Leyton C; González MJ
Arthritis Rheum; 2010 May; 62(5):1280-9. PubMed ID: 20131287
[TBL] [Abstract][Full Text] [Related]
8. Zonula occludens-1, occludin and E-cadherin expression and organization in salivary glands with Sjögren's syndrome.
Mellas RE; Leigh NJ; Nelson JW; McCall AD; Baker OJ
J Histochem Cytochem; 2015 Jan; 63(1):45-56. PubMed ID: 25248927
[TBL] [Abstract][Full Text] [Related]
9. Aspirin Triggered Resolvin D1 reduces inflammation and restores saliva secretion in a Sjögren's syndrome mouse model.
Dean S; Wang CS; Nam K; Maruyama CL; Trump BG; Baker OJ
Rheumatology (Oxford); 2019 Jul; 58(7):1285-1292. PubMed ID: 30877775
[TBL] [Abstract][Full Text] [Related]
10. Synaptotagmin-1 overexpression under inflammatory conditions affects secretion in salivary glands from Sjögren's syndrome patients.
Cortés J; Hidalgo J; Aguilera S; Castro I; Brito M; Urra H; Pérez P; Barrera MJ; Carvajal P; Urzúa U; González S; Molina C; Bahamondes V; Hermoso M; González MJ
J Autoimmun; 2019 Feb; 97():88-99. PubMed ID: 30391023
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma alter tight junction structure and function in the rat parotid gland Par-C10 cell line.
Baker OJ; Camden JM; Redman RS; Jones JE; Seye CI; Erb L; Weisman GA
Am J Physiol Cell Physiol; 2008 Nov; 295(5):C1191-201. PubMed ID: 18768927
[TBL] [Abstract][Full Text] [Related]
12. The G-Protein-Coupled Receptor ALX/Fpr2 Regulates Adaptive Immune Responses in Mouse Submandibular Glands.
Wang CS; Baker OJ
Am J Pathol; 2018 Jul; 188(7):1555-1562. PubMed ID: 29684359
[TBL] [Abstract][Full Text] [Related]
13. Disruption of endothelial barrier function is linked with hyposecretion and lymphocytic infiltration in salivary glands of Sjögren's syndrome.
Cong X; Zhang XM; Zhang Y; Wei T; He QH; Zhang LW; Hua H; Lee SW; Park K; Yu GY; Wu LL
Biochim Biophys Acta Mol Basis Dis; 2018 Oct; 1864(10):3154-3163. PubMed ID: 29981359
[TBL] [Abstract][Full Text] [Related]
14. Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis.
Lee HN; Surh YJ
Biochem Pharmacol; 2013 Sep; 86(6):759-69. PubMed ID: 23856291
[TBL] [Abstract][Full Text] [Related]
15. Specialized pro-resolving receptors are expressed in salivary glands with Sjögren's syndrome.
Dos Santos HT; Nam K; Maslow F; Trump B; Baker OJ
Ann Diagn Pathol; 2022 Feb; 56():151865. PubMed ID: 34847389
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide/vasoactive intestinal peptide receptor relative expression in salivary glands as one endogenous modulator of acinar cell apoptosis in a murine model of Sjögren's syndrome.
Hauk V; Calafat M; Larocca L; Fraccaroli L; Grasso E; Ramhorst R; Leirós CP
Clin Exp Immunol; 2011 Dec; 166(3):309-16. PubMed ID: 22059987
[TBL] [Abstract][Full Text] [Related]
17. Role of cytokines in the destruction of acinar structure in Sjögren's syndrome salivary glands.
Azuma M; Motegi K; Aota K; Hayashi Y; Sato M
Lab Invest; 1997 Sep; 77(3):269-80. PubMed ID: 9314950
[TBL] [Abstract][Full Text] [Related]
18. Functions of resolvin D1-ALX/FPR2 receptor interaction in the hemoglobin-induced microglial inflammatory response and neuronal injury.
Liu GJ; Tao T; Wang H; Zhou Y; Gao X; Gao YY; Hang CH; Li W
J Neuroinflammation; 2020 Aug; 17(1):239. PubMed ID: 32795323
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17 Impairs Salivary Tight Junction Integrity in Sjögren's Syndrome.
Zhang LW; Cong X; Zhang Y; Wei T; Su YC; Serrão AC; Brito AR; Yu GY; Hua H; Wu LL
J Dent Res; 2016 Jul; 95(7):784-92. PubMed ID: 26933138
[TBL] [Abstract][Full Text] [Related]
20. Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients.
Barrera MJ; Aguilera S; Castro I; Cortés J; Bahamondes V; Quest AFG; Molina C; González S; Hermoso M; Urzúa U; Leyton C; González MJ
J Autoimmun; 2016 Dec; 75():68-81. PubMed ID: 27461470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]